ES2549610T3 - Método de diagnóstico para detectar la lesión renal aguda a través del uso de la proteína de choque térmico de 72 como un biomarcador sensible - Google Patents

Método de diagnóstico para detectar la lesión renal aguda a través del uso de la proteína de choque térmico de 72 como un biomarcador sensible Download PDF

Info

Publication number
ES2549610T3
ES2549610T3 ES10831836.1T ES10831836T ES2549610T3 ES 2549610 T3 ES2549610 T3 ES 2549610T3 ES 10831836 T ES10831836 T ES 10831836T ES 2549610 T3 ES2549610 T3 ES 2549610T3
Authority
ES
Spain
Prior art keywords
diagnostic method
thermal shock
shock protein
biomarker
kidney injury
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10831836.1T
Other languages
English (en)
Spanish (es)
Inventor
Norma Araceli Bobadilla Sandoval
Jonatan Barrera Chimal
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NAC AUTONOMA DE MEXICO, University of
Universidad Nacional Autónoma de México
Original Assignee
NAC AUTONOMA DE MEXICO, University of
Universidad Nacional Autónoma de México
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NAC AUTONOMA DE MEXICO, University of, Universidad Nacional Autónoma de México filed Critical NAC AUTONOMA DE MEXICO, University of
Application granted granted Critical
Publication of ES2549610T3 publication Critical patent/ES2549610T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ES10831836.1T 2009-11-23 2010-11-23 Método de diagnóstico para detectar la lesión renal aguda a través del uso de la proteína de choque térmico de 72 como un biomarcador sensible Active ES2549610T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
MX09012633 2009-11-23
MX2009012633A MX2009012633A (es) 2009-11-23 2009-11-23 Metodo de diagnostico para detectar la lesion renal aguda a traves del uso de la proteina de choque termico de 72 kda como un biomarcador sensible.
PCT/MX2010/000138 WO2011062469A2 (es) 2009-11-23 2010-11-23 Método de diagnóstico para detectar la lesión renal aguda a través del uso de la proteína de choque térmico de 72 kda como un biomarcador sensible

Publications (1)

Publication Number Publication Date
ES2549610T3 true ES2549610T3 (es) 2015-10-29

Family

ID=44060228

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10831836.1T Active ES2549610T3 (es) 2009-11-23 2010-11-23 Método de diagnóstico para detectar la lesión renal aguda a través del uso de la proteína de choque térmico de 72 como un biomarcador sensible

Country Status (8)

Country Link
US (1) US20130065239A1 (enExample)
EP (1) EP2506016B1 (enExample)
JP (1) JP5755657B2 (enExample)
CN (1) CN102762985B (enExample)
CA (1) CA2781754C (enExample)
ES (1) ES2549610T3 (enExample)
MX (1) MX2009012633A (enExample)
WO (1) WO2011062469A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013529907A (ja) 2010-05-24 2013-07-25 ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク Ｎｇａｌタンパク質変異体及びその使用
NZ605698A (en) 2010-06-23 2015-03-27 Astute Medical Inc Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CA2846602A1 (en) 2011-08-26 2013-03-28 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN102879584A (zh) * 2012-09-26 2013-01-16 中国人民解放军军事医学科学院基础医学研究所 一种人血液hsp70抗体胶体金标检测试纸条及其制备方法
EP2925337B1 (en) 2012-11-21 2019-07-03 The Trustees of Columbia University in the City of New York Mutant ngal proteins and uses thereof
KR101468047B1 (ko) * 2013-01-16 2014-12-02 고려대학교 산학협력단 열충격단백질군의 mRNA 발현 양상 분석을 통한 사인 추정방법
CN110431422A (zh) 2017-02-06 2019-11-08 机敏医药股份有限公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
CN107045594B (zh) * 2017-04-25 2018-06-26 吉林大学 一种脊柱损伤测量中x射线标志物的数字化系统
WO2020125806A1 (en) 2018-12-17 2020-06-25 Shanghai United Imaging Intelligence Co., Ltd. Systems and methods for image segmentation
CN109754394B (zh) * 2018-12-28 2021-02-23 上海联影智能医疗科技有限公司 三维医学图像处理装置及方法
CN111007255A (zh) * 2019-12-10 2020-04-14 江苏三联生物工程有限公司 一种用于肾损伤标志物检测的蛋白芯片及其制备方法
CN116449024A (zh) * 2023-04-13 2023-07-18 武汉市第三医院 Saa1作为生物标志物在预测或诊断急性肾损伤中的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4035591B2 (ja) * 2003-01-24 2008-01-23 株式会社三重ティーエルオー 血管障害病態改善剤
WO2007013919A2 (en) * 2005-07-21 2007-02-01 The Johns Hopkins University Methods of detecting and treating acute kidney injury

Also Published As

Publication number Publication date
CN102762985A (zh) 2012-10-31
US20130065239A1 (en) 2013-03-14
MX2009012633A (es) 2011-05-24
WO2011062469A8 (es) 2012-01-12
EP2506016B1 (en) 2015-07-08
WO2011062469A3 (es) 2011-11-24
EP2506016A4 (en) 2013-01-23
JP2013511735A (ja) 2013-04-04
WO2011062469A2 (es) 2011-05-26
CN102762985B (zh) 2015-06-17
CA2781754A1 (en) 2011-05-26
EP2506016A2 (en) 2012-10-03
CA2781754C (en) 2019-09-03
JP5755657B2 (ja) 2015-07-29

Similar Documents

Publication Publication Date Title
Reisinger et al. Sarcopenia is associated with an increased inflammatory response to surgery in colorectal cancer
Yu et al. Expression of interleukin-22/STAT3 signaling pathway in ulcerative colitis and related carcinogenesis
MX2009003562A (es) Ensayo elisa para la deteccion de vegf.
Leung et al. Ovarian cancer biomarkers: current state and future implications from high-throughput technologies
BR112014020213A2 (pt) biomarcadores para o diagnóstico, o prognóstico, a avaliação e a estratificação de terapia de síncope
WO2011062469A3 (es) Método de diagnóstico para detectar la lesión renal aguda a través del uso de la proteína de choque térmico de 72 kda como un biomarcador sensible
Rafiei et al. Kidney stone development among older adults in Iran
Du et al. Serum thyroglobulin as a biomarker of iodine excess and thyroid disease occurrence in adults
CN104215774B (zh) 一种利用fgf21因子诊断奶牛隐性酮病的方法
RU2010145662A (ru) Способ прогнозирования риска смерти больных хронической сердечной недостаточностью
Oikonomou et al. Downregulation of serum epidermal growth factor in patients with inflammatory bowel disease. Is there a link with mucosal damage?
TW201030340A (en) Method for renal disease diagnosis and prognosis using annexin a1 and rab23 as markers
CN103834663A (zh) 一种血清淀粉样蛋白a及其编码基因和应用
Ataollahi et al. Diagnostic value of cardiac troponin I (cTnI), creatine kinase (CK), and aspartate amino transferase (AST) in selenium defciency in lambs
CN104263809A (zh) 一种通过体外酶消化法评定豆粕家禽有效氨基酸含量的方法
Pinto et al. Age-related changes in the renal dopaminergic system and expression of renal amino acid transporters in WKY and SHR rats
Egea-Valenzuela et al. Calprotectina fecal como predictor de lesiones inflamatorias en intestino delgado diagnosticadas con cápsula endoscópica
Megahed et al. The effects of sample temperature on the concentrations of glucose and β-OH butyrate measured by the Precision Xtra meter in plasma from periparturient dairy cattle
Guyot et al. Accuracy of inflammation field tests in cattle practice
Guyot et al. Serum cardiac troponin I concentrations as a diagnostic aid of pericarditis in cattle
Chen et al. Variation of urine N-acetyl-β-D-glucosaminidase activity in patients with acute kidney injury after percutaneous nephrolithotomy and its clinical significance
ES2382960B1 (es) Aminopeptidasas como marcadores de daño renal
Conway et al. Desperate for a hot shower
Musialowska et al. ENDOCAN CONCENTRATION IN HYPERTENSIVE PATIENTS
RU2011117771A (ru) Способ постановки диагноза у больного в критическом состоянии